🎁  Special Promo: 15% off for new account creator CREATE2026 ✦  Limited Offer: 20% off seleced Product 2026Q4WB 🔬  New Product Launch: Human Primary Cells

MileCell Expands European Distribution Through Tebubio

Tebubio partners with MileCell Biotechnology, a specialist provider of high-quality primary cells, subcellular fractions and biospecimens for drug metabolism, pharmacokinetics and toxicology research. Through this collaboration, Tebubio will make MileCell’s complete portfolio available to researchers across Europe, further strengthening its offering for ADME-Tox, hepatic and extra-hepatic research.

MileCell provides a comprehensive range of human and animal biological materials designed to support drug discovery, development and safety assessment. Its portfolio includes subcellular fractions, such as microsomes, S9 fractions and homogenates, alongside primary cells, including hepatocytes, Kupffer cells and PBMCs, as well as a broad selection of biological fluids and other biospecimens.

These biological materials support a wide range of ADME-Tox applications, including drug-induced liver injury (DILI), metabolite identification (MetID), metabolic stability and clearance, enzyme induction, transporter studies and toxicity assessment.

By adding MileCell’s portfolio, Tebubio expands the choice of biological models available to researchers investigating both hepatic and extra-hepatic metabolism and toxicity, helping them select biological materials suited to their experimental requirements and drug development programmes.

Beyond ADME-Tox, MileCell also provides selected solutions for cell and gene therapy research, including MagSep™ nanomagnetic beads + kits for immune cell isolation (positive or negative selection),  and Kryogene™ cell freezing media (CAR-T, etc.), including Type II US-DMFs supporting researchers in the development, optimisation, and commercialization of cell-based CGT workflows.

Through the partnership, Tebubio will provide access to MileCell’s complete product portfolio, combined with local scientific support to help researchers identify the most appropriate biological materials for their applications.

Donald van Dijk, CEO of Tebubio, said:
“Our partnership with MileCell strengthens our ADME-Tox offering and gives European researchers access to a broader range of high-quality human and animal biological materials. By combining MileCell’s expertise with Tebubio’s local scientific support, we can help researchers find the right solutions for their experimental needs.”

Nianwei Lin, CEO of MileCell, added:
MileCell’s commitment to providing high-quality and well-characterised biological materials, and the value of Tebubio’s European presence and scientific expertise in making these solutions more accessible to researchers.

 

About MileCell Biotechnology

MileCell Biotechnology (San Diego, CA) manufactures and supplies high-quality human and animal primary cells (including non-human primate), hepatocytes, liver subcellular fractions (including S9 fractions + microsomes), peripheral blood mononuclear cells (PBMCs), isolated immune cells, cell culture/cryopreservation media, biospecimens and reagents for life science research and drug discovery. MileCell’s products support ADME/DMPK, drug metabolism, toxicity testing, disease research, and cell and gene therapy development and manufacturing. MileCell serves pharmaceutical and biotechnology companies, contract research organizations (CROs), academic and research institutions, and cell and gene therapy organizations worldwide.

Contact: Wayne Vaz – Chief Commercial Officer – wayne.vaz@milecell-bio.com

About Tebubio

Tebubio facilitates Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions enabling them to access cutting-edge solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance.

Contact : Cyrielle Delafoy, Corporate Communications – marketing@tebubio.com